Literature DB >> 12873431

L-[1-13C] phenylalanine breath test reflects phenylalanine hydroxylase activity of the whole liver.

Yukimoto Ishii1, Shigeru Suzuki, Tomohisa Kohno, Masaru Aoki, Tadashi Kohno, Asuka Ito, Tadatoshi Takayama, Satoshi Asai.   

Abstract

OBJECT: The purpose of this study was to perform L-[1-13C] phenylalanine breath test (PBT), measure phenylalanine hydroxylase (PAH) activity in liver tissue biopsies from patients, analyze the relationship between PBT results and PAH activity, and determine the time point at which measurements best reflect PAH activity in liver tissue.
METHODS: PBT was performed in 25 patients (10 with normal liver and 15 with liver cirrhosis). After administering 10 mg/kg L-[1-13C] phenylalanine, 300 ml of expired air was collected over 90 min at 15-min intervals. The rate of hepatic phenylalanine oxidation (%13C dose h(-1)) at each time point was calculated from the amount of 13CO(2) in the breath, assuming a CO(2) production rate of 300 mmol m(-2) body surface area per hour. Subsequently, we examined the relationship between the results of PBT and PAH activity.
RESULTS: PAH activity of the whole liver was significantly decreased in hepatic cirrhosis patients (P < 0.05). The results of PBT %13C dose h(-1) correlated with the PAH activity/liver, with correlation coefficients at 30, 45, and 60 min of more than 0.7, and the maximum correlation was at 30 min (r = 0.821, P < 0.0001). %13C cumulative excretion correlated with the PAH activity/liver with correlation coefficients of more than 0.7 after 45 min. The maximum correlation was at 90 min (r = 0.770, P = 0.001).
CONCLUSION: PBT values reflect PAH activity in the whole liver and, in particular, the % dose h(-1) at 30 min after oral administration highly correlates with PAH activity, providing an important indicator for monitoring changes in whole liver PAH activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12873431     DOI: 10.1016/s0022-4804(03)00135-5

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  2 in total

1.  Clinical research on liver reserve function by 13C-phenylalanine breath test in aged patients with chronic liver diseases.

Authors:  Gan-sheng Zhang; Zhi-jun Bao; Jian Zou; Shu-ming Yin; Yi-qin Huang; Hai Huang; De-kai Qiu
Journal:  BMC Geriatr       Date:  2010-05-12       Impact factor: 3.921

2.  13C-phenylalanine breath test detects altered phenylalanine kinetics in schizophrenia patients.

Authors:  T Teraishi; Y Ozeki; H Hori; D Sasayama; S Chiba; N Yamamoto; H Tanaka; Y Iijima; J Matsuo; Y Kawamoto; Y Kinoshita; K Hattori; M Ota; M Kajiwara; S Terada; T Higuchi; H Kunugi
Journal:  Transl Psychiatry       Date:  2012-05-22       Impact factor: 6.222

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.